|
SMG1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.064300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.674300E-02 |
| Normal-vs-Stage2 |
3.258400E-01 |
| Normal-vs-Stage3 |
6.044000E-03 |
| Normal-vs-Stage4 |
7.420100E-03 |
| Stage1-vs-Stage2 |
7.225800E-01 |
| Stage1-vs-Stage3 |
1.197970E-01 |
| Stage1-vs-Stage4 |
2.056400E-01 |
| Stage2-vs-Stage3 |
1.869160E-01 |
| Stage2-vs-Stage4 |
2.490400E-01 |
| Stage3-vs-Stage4 |
9.005800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.645940E-02 |
| Normal-vs-AfricanAmerican |
5.230500E-02 |
| Normal-vs-Asian |
1.417420E-01 |
| Caucasian-vs-AfricanAmerican |
8.351200E-01 |
| Caucasian-vs-Asian |
2.094300E-02 |
| AfricanAmerican-vs-Asian |
2.845900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.070400E-02 |
| Normal-vs-Female |
4.652100E-02 |
| Male-vs-Female |
5.866400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.342170E-02 |
| Normal-vs-Age(41-60Yrs) |
2.212600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.375600E-03 |
| Normal-vs-Age(81-100Yrs) |
6.926100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.850200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.748200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.986200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.127700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.606200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.523800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.535200E-01 |
| Normal-vs-Grade 2 |
2.024600E-01 |
| Normal-vs-Grade 3 |
2.781500E-03 |
| Normal-vs-Grade 4 |
2.084500E-03 |
| Grade 1-vs-Grade 2 |
9.788300E-02 |
| Grade 1-vs-Grade 3 |
6.840300E-03 |
| Grade 1-vs-Grade 4 |
4.440800E-03 |
| Grade 2-vs-Grade 3 |
3.643800E-02 |
| Grade 2-vs-Grade 4 |
2.931800E-02 |
| Grade 3-vs-Grade 4 |
4.095600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.223200E-01 |
| Normal-vs-ccB subtype |
2.624500E-03 |
| ccA subtype-vs-ccB subtype |
4.040600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.160200E-02 |
| Normal-vs-N1 |
7.251800E-02 |
| N0-vs-N1 |
4.432000E-01 |
|
|
